This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Accuredit Therapeutics (Suzhou) Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jialin Tao: Innovator in Base Editing Technologies
Introduction
Jialin Tao is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of genetic engineering, particularly in the area of base editing technologies. His innovative work has the potential to revolutionize genetic modifications and therapeutic applications.
Latest Patents
Jialin Tao holds 1 patent for his invention titled "Deaminases and variants thereof for use in base editing." This patent provides a detailed description of adenosine deaminases and their variants, which are crucial for nucleobase editing. The invention includes compositions comprising these editors and methods for generating modifications in target nucleobase sequences.
Career Highlights
Jialin Tao is currently employed at Accuredit Therapeutics (Suzhou) Co., Ltd. His role at the company allows him to further develop his innovative ideas and contribute to advancements in the biotechnology sector. His expertise in base editing has positioned him as a key figure in this rapidly evolving field.
Collaborations
Jialin collaborates with talented individuals such as Feifei Duan and Huanle Liu. These partnerships enhance the research and development efforts at Accuredit Therapeutics, fostering an environment of innovation and creativity.
Conclusion
Jialin Tao's work in base editing technologies exemplifies the impact of innovative thinking in biotechnology. His contributions are paving the way for future advancements in genetic engineering and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile